Characterization of Dermal Reactions in Pediatric Patients With ADHD Using DAYTRANA

NCT00434213 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

309

Enrollment

INDUSTRY

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: Daytrana

Sponsor

Noven Therapeutics